Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Technology
Share your love
Novel Gene Editing Breakthrough for Eye Conditions
Researchers at the Broad Institute of MIT and Harvard have made a breakthrough in gene editing technology, introducing a new method for delivering prime editing tools into cells of living animals. This advancement, detailed in a study published in Nature…
Study Finds Neurolens Lenses Reduce Headache
Neurolens announced the findings of a research study aimed at evaluating the efficacy of its prescription lenses for individuals suffering from headaches. Conducted across 10 optometry practices involving 195 patients, this company-sponsored study utilized the six-item Headache Impact Test (HIT-6)…
The Optical Company Acquires Adelaide Eye Care
In a landmark move that expands its network to 60 locations, The Optical Company (TOC) has officially acquired all three Adelaide Eye Care (AEC) optometry practices. This expansion is the first major acquisition for TOC in 2024, adding to a…
Pediatric Cataract Surgery Restores Vision for Infant
Nethradhama Super Speciality Eye Hospitals achieved a remarkable feat in pediatric eye care with the successful completion of a high-risk paediatric cataract surgery on an 8-month-old baby in Bangalore. Led by Dr. Sri Ganesh, a distinguished eye surgeon and the…
Faster, Cheaper 3D Printing for Artificial Eyeballs
A team of biomedical and ophthalmological researchers from various European institutions, in collaboration with computer graphics specialists, has unveiled a novel technique for 3D printing artificial eyeballs. Published in the esteemed journal Nature Communications, their innovative approach promises to revolutionize…
Optos Celebrates Worldwide Installations & Clinical Studies
Optos PLC celebrates two significant achievements: the global installation of over 25,000 devices and the accomplishment of 2,500 clinical and peer-reviewed studies covering 235 disease states. These milestones underscore Optos’ over three decades of innovation and its substantial impact on elevating…
Amring Names Dr. Donnenfeld as U.S. Advisory Board Chair
Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V., announced the appointment of Dr. Eric D. Donnenfeld, a distinguished figure in ophthalmology, as the Chair of its U.S. Medical Advisory Board (MAB). This strategic decision comes as the company gears…
Eversight Partners with Emmecell for Ocular Therapy Advances
Eversight, a leading non-profit dedicated to the restoration of sight through the recovery, processing, and distribution of corneal tissue, announced a strategic partnership with Emmecell Biotech, a biotechnology company focused on developing novel cell therapies for ocular diseases. This collaboration…
VSY Biotechnology’s 100% Glistening-Free IOL Material
VSY Biotechnology GmbH is pushing the boundaries of ophthalmology with its cutting-edge 100% Glistening-Free IOL Material. In a statement, Andreas Kühnel, the Managing Director at VSY Biotechnology GmbH, expressed his excitement about the groundbreaking innovation, saying, “This innovative solution, developed…
A Novel Approach To Trifocal IOLs
AcrivaUD Trinova is the world’s first and only sinusoidal trifocal IOL manufactured with Sinusoidal Vision Technology (SVT). Its sinusoidal optic design eliminates the sharp steps (diffractive rings) found with traditional trifocal IOLs. The smoothly varying surface profile derived from the…